The rise and fall of NMDA antagonists for ischemic stroke.

The rise and fall of NMDA antagonists for ischemic stroke.

It has long been accepted that high concentrations of glutamate can destroy neurons, and this is the basis of the theory of excitotoxicity during brain injury such as stroke. Glutamate N-methyl-D-aspartate (NMDA) receptor antagonists such as Selfotel, Aptiganel, Gavestinel and others failed to show...

Bibliografiset tiedot
Päätekijät:	Hoyte, L, Barber, P, Buchan, A, Hill, MD
Aineistotyyppi:	Journal article
Kieli:	English
Julkaistu:	2004

Samankaltaisia teoksia

NMDA antagonists: their role in neuroprotection.
Tekijä: Small, D, et al.
Julkaistu: (1997)

NMDA antagonists: their role in neuroprotection.
Tekijä: Small, D, et al.
Julkaistu: (1997)

Do NMDA antagonists prevent neuronal injury? No.
Tekijä: Buchan, A
Julkaistu: (1992)

AMPA antagonists: do they hold more promise for clinical stroke trials than NMDA antagonists?
Tekijä: Buchan, A, et al.
Julkaistu: (1993)

The effect of the NMDA receptor antagonist MK-801 on cerebral blood flow and infarct volume in experimental focal stroke.
Tekijä: Buchan, A, et al.
Julkaistu: (1992)

Effectiveness of t-PA in acute ischemic stroke: outcome relates to appropriateness.
Tekijä: Buchan, A, et al.
Julkaistu: (2000)

Do NMDA antagonists protect against cerebral ischemia: are clinical trials warranted?
Tekijä: Buchan, A
Julkaistu: (1990)

Biochemistry of ischemic stroke.
Tekijä: Barber, P, et al.
Julkaistu: (2003)

Time is brain: Post-marketing experience with alteplase (tPA) for acute ischemic stroke
Tekijä: Hill, MD, et al.
Julkaistu: (2000)

Intra-arterial therapy following intravenous alteplase for severe ischemic stroke
Tekijä: Hill, MD, et al.
Julkaistu: (2001)

Delayed treatment with AMPA, but not NMDA, antagonists reduces neocortical infarction.
Tekijä: Xue, D, et al.
Julkaistu: (1994)

POSTISCHEMIC TREATMENT WITH AMPA, BUT NOT NMDA, ANTAGONISTS PREVENTS CA1 NEURONAL INJURY
Tekijä: Li, H, et al.
Julkaistu: (1992)

Anaphylactoid reactions and angioedema during alteplase treatment of acute ischemic stroke.
Tekijä: Hill, MD, et al.
Julkaistu: (2000)

Understanding and managing ischemic stroke.
Tekijä: Barber, P, et al.
Julkaistu: (2001)

DELAYED TREATMENT WITH AMPA BUT NOT NMDA GLUTAMATE ANTAGONISTS REDUCES NEOCORTICAL INFARCTION
Tekijä: Xue, D, et al.
Julkaistu: (1992)

Improved regional cerebral blood flow is important for the protection seen in a mouse model of late phase ischemic preconditioning.
Tekijä: Hoyte, L, et al.
Julkaistu: (2006)

Thrombolysis for acute ischemic stroke: results of the Canadian Alteplase for Stroke Effectiveness Study.
Tekijä: Hill, MD, et al.
Julkaistu: (2005)

HYPOTHERMIA BUT NOT NMDA RECEPTOR ANTAGONIST MK-801 ATTENUATES NEURON DAMAGE - ARE THE RESULTS CONCLUSIVE - REPLY
Tekijä: Buchan, A, et al.
Julkaistu: (1992)

Neuroprotection, excitotoxicicity and nmda antagonists
Tekijä: RUBENS JOSÉ GAGLIARDI
Julkaistu: (2000-06-01)

Animal Models of Stroke
Tekijä: Hoyte, L, et al.
Julkaistu: (2010)

Organised stroke care increases the numbers and the speed with which patients with acute ischemic stroke are thrombolysed
Tekijä: Kennedy, J, et al.
Julkaistu: (2002)

Is alteplase safe and effective in routine clinical practice for patients with ischemic stroke?
Tekijä: Buchan, A, et al.
Julkaistu: (2007)

Building a "brain attack" team to administer thrombolytic therapy for acute ischemic stroke.
Tekijä: Hill, MD, et al.
Julkaistu: (2000)

NMDA Receptor Antagonists for Treatment of Depression
Tekijä: Zeynep Ates-Alagoz, et al.
Julkaistu: (2013-04-01)

Effectiveness of tissue-type plasminogen activator for acute ischemic stroke: Consequences of protocol violation
Tekijä: Karbalai, H, et al.
Julkaistu: (1999)

NEUROPROTECTIVE PROFILE OF FPL-15896AR, A NOVEL UNCOMPETITIVE NMDA ANTAGONIST
Tekijä: Murray, R, et al.
Julkaistu: (1995)

Opioid Antagonist in the Treatment of Ischemic Stroke
Tekijä: Juan Fernando Ortiz, et al.
Julkaistu: (2021-06-01)

Outcomes of thrombolysis for acute ischemic stroke in octogenarians versus nonagenarians.
Tekijä: Mateen, F, et al.
Julkaistu: (2010)

THE NMDA RECEPTOR-ION CHANNEL - ITS IMPORTANCE TO INVIVO ISCHEMIC-INJURY TO SELECTIVELY VULNERABLE NEURONS
Tekijä: Pulsinelli, W, et al.
Julkaistu: (1990)

Correction: Diagnostic Potential of the NMDA Receptor Peptide Assay for Acute Ischemic Stroke.
Tekijä: Svetlana A Dambinova, et al.
Julkaistu: (2013-01-01)

Informed consent for thrombolytic therapy in acute ischemic stroke.
Tekijä: Sivakumar, C, et al.
Julkaistu: (2005)

Acute ischaemic stroke. Thrombolysis for acute ischaemic stroke works.
Tekijä: Hill, MD, et al.
Julkaistu: (2000)

NMDA receptor antagonists in the treatment of neurological diseases
Tekijä: I. S. Preobrazhenskaya
Julkaistu: (2020-10-01)

PSYCHOPHARMACOLOGICAL PROFILE OF THE NMDA RECEPTOR ANTAGONIST MK-801
Tekijä: Iversen, S, et al.
Julkaistu: (1987)

Thrombolytic therapy for acute ischemic stroke - The CAEP Position Statement: another perspective.
Tekijä: Hill, MD, et al.
Julkaistu: (2001)

Antagonism of the NMDA and non-NMDA receptors in global versus focal brain ischemia.
Tekijä: Pulsinelli, W, et al.
Julkaistu: (1993)

Early T1- and T2-weighted MRI signatures of transient and permanent middle cerebral artery occlusion in a murine stroke model studied at 9.4T.
Tekijä: Barber, P, et al.
Julkaistu: (2005)

Cold Pain Threshold and Role of NMDA Receptor Antagonists
Tekijä: Poroshat Nazemi, et al.
Julkaistu: (2019-01-01)

Thrombolysis for acute ischemic stroke in patients older than 80 years
Tekijä: N, S, et al.
Julkaistu: (2006)

The Canadian activase for stroke effectiveness study (CASES)
Tekijä: Hill, MD, et al.
Julkaistu: (2000)